Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer?

PURPOSE: For patients with triple negative breast cancer (TNBC), the optimal time to initiate neoadjuvant chemotherapy (TTNC) is unknown. This study evaluates the association between TTNC and survival in patients with early TNBC. METHODS: A retrospective study using data from of a cohort of TNBC pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatzipanagiotou, Maria Eleni, Pigerl, Miriam, Gerken, Michael, Räpple, Sophie, Zeltner, Verena, Hetterich, Madeleine, Ugocsai, Peter, Fernandez-Pacheco, Miriam, Inwald, Elisabeth Christine, Klinkhammer-Schalke, Monika, Ortmann, Olaf, Seitz, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465651/
https://www.ncbi.nlm.nih.gov/pubmed/37418056
http://dx.doi.org/10.1007/s00432-023-05060-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465651/
https://www.ncbi.nlm.nih.gov/pubmed/37418056
http://dx.doi.org/10.1007/s00432-023-05060-y

Ejemplares similares